Ifosfamide encephalopathy and methylene-blue: A case report [2]

Annals of Oncology

Volumn 7, Issue 6, 1996, Pages 643-644

  Alonso, J L ^a   Nieto, Y ^a   Lopez, J A ^a   Martin, M ^a   Diaz Rubino, E ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; LORAZEPAM; MESNA; METHYLENE BLUE; ONDANSETRON; PACLITAXEL;

ADULT; BRAIN DISEASE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029795512     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010686     Document Type: Letter

References (6)

1. Curtin J.P. Koonings P.P. Gutierrez M. Ifosfamide-induced neurotoxicity Gynecol Oncol 42 3 1991 193 196
2. Meanwell C.A. Blake A.E. Blackledge G. Encephalopathy associated with ifosfamide/mesna therapy Lancet 1985 406 407
3. Küpfer A. Aeschlimann C. Wermuth B. Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue Lancet 343 1994 763 764
4. Harpey J.P. Charpentier C. Coudi M. Methylene-blue for riboflavin-unresponsive glutaricaciduria type II Lancet i 1986 391
5. Salloum E. Flamant F. Ghosn M. Irreversible encephalo-pathy with ifosfamide/mesna J Clin Oncol 5 1987 1303 1304
6. Meanwell C.A. Blake A.E. Kelly K.A. Prediction of ifosfamide/mesna associated encephalopathy Eur J Cancer Clin Oncol 22 1986 815 819